Thesis (doctoral)--Lund University, 1997. / Added t.p. with thesis statement inserted.

Thesis (doctoral)--Lund University, 1995. / Added t.p. with thesis statement inserted.

Thesis (doctoral)--Lund University, 1997. / Added t.p. with thesis statement inserted.

Thesis (doctoral)--München, 1934.

Thesis (doctoral)--Lund University, 1995. / Added t.p. with thesis statement inserted.

Les Alphavirus sont des virus à ARN enveloppés, d’un diamètre de 70 nm, à structure icosaédrique à symétrie de type T=4 (Choi et al. 1991; Cheng et al. 1995; Garoff et al. 2004). Ces virus, dont la répartition est mondiale, sont capables d’infecter une grande variétés d’animaux vertébrés (mammifères, oiseaux, poissons). Ces virus sont des arbovirus, c’est-à_dire des virus transmis par des arthropodes. Dans le cas des Alphavirus, la vectorisation est faite par des moustiques appartenant à plusieurs espèces. A ce jour, 29 espèces d’Alphavirus ont été identifiés, dont au moins 6 sont pathogènes pour l’Homme. Chez l’Homme, certains Alphavirus sont responsables d'encéphalites, d'arthrites, de fièvres, d'éruptions cutanées et peuvent être fatals (Thiruvengadam et al. 1965; Pialoux et al. 2006).Le premier Alphavirus isolé fut l'Encephalite Equine de l'Ouest (WEEV), en 1930 (Meyer et al. 1931). Les virus de l'encéphalite de l'Est (VEEV) et le virus de l'Encephalite Equine du Vénézuéla (VEEV) furent isolés respectivement en 1933 et 1938 (Gibbs EP. 1976 ; Beck et al. 1938 ; Kubes et al. 1939). Le Virus Sindbis isolé en Egypte en 1952 (Taylor et al. 1955), fut le premier Alphavirus responsables d’arthrites à être isolé. La mise en évidence de l'existence du CHIKV se fera 1952 en Tanzanie (Robinson 1955) (Lumsden 1955). Suivent alors les découvertes de l'ensemble des autres Alphavirus. Le South Elephent Seal virus (SESV), identifié en 2000 sur l'île australienne de Macquarie, est à l’heure actuelle le dernier Alphavirus découvert. La phylogénétique des souches de Chikungunya permet d’identifier des clades différents pour les souches d’Afrique de l’Est, de l’Ouest ou d’Asie, et l’analyse phylogénétique est très proche du O’Nyong-Nyong (Powers et al. 2000), Le séquençage de différents isolats de l’épidémie de 2005, a permis de mettre en évidence chez certains d’entre eux une mutation dans la glycoprotéine de l'enveloppe plus précisément dans E1, (Schuffenecker et al. 2006). Cette mutation entraine la substitution d'une arginine en position 226 au lieu de la valine (A226V), est un élément clé pour déterminer le choix d'un nouveau vecteur pour la transmission ou Aedes albopictus (qui le transmet sur l'île de La Réunion) par rapport au vecteur Aedes aegypti (Tsetsarkin et al. 2007). Cette mutation a ensuite été également trouvée en Inde en 2007. (Arankalle et al. 2007; Kumar et al. 2008; Santhosh et al. 2008).Le tableau clinique classique débute souvent par l’apparition brutale d’une forte fièvre (40°C) pendant 3 / 10 jours accompagnée de frissons intermittents (Deller et al.1967). La fièvre est, dans certains cas, bi-phasique, c’est-à-dire qu’elle diminue durant un ou deux jours, avant de remonter brutalement. Elle est généralement suivie d’érythèmes, de courbatures douloureuses ou myalgies et douleurs musculaires (Ozden et al. 2007) en particulier celles impliquant la douleur au niveau des extrémités (poignés, phalanges et chevilles) (Robinson 1955; Jadhav et al. 1965; Thiruvengadam et al. 1965). Egalement migraine, éruptions cutanées maculo-papuleuses parfois prurigineuses. L'éruption touchant le thorax et le visage les mains et les pieds, chez les enfants ont été observées des éruptions de type bulleux accompagné par un détachement cutané (Talarmin et al. 2007). L'évolution de la maladie régresse progressivement. Il n’y a aucun traitement antiviral efficace contre le CHIKV. Le traitement est donc essentiellement symptomatique et composé d'antalgiques non salicylés, de paracétamol et d'anti-inflammatoires non stéroïdiens. Ce travail se compose de deux parties : 1 partie sur l’étude phylogénétique du CHIKV et 1 partie sur l'étude des molécules antivirales. [...] / The Alphavirus RNA viruses are enveloped with a diameter of 70 nm, icosahedral structure with symmetry of type T = 4 (Choi et al. 1991; Cheng et al. 1995; Garoff et al. 2004). These viruses, whose distribution is worldwide, can infect a wide variety of vertebrates (mammals, birds, fish). These viruses are arboviruses, is à_dire viruses transmitted by arthropods. In the case of Alphavirus, the vectorization is done by mosquitoes from several species.To date, 29 species of Alphavirus have been identified, including at least six are pathogenic for humans. In humans, some are responsible for Alphavirus encephalitis, arthritis, fever, rash and can be fatal (Thiruvengadam et al. 1965; Pialoux et al. 2006).The first was isolated Alphavirus Equine Encephalitis West (Weeve) in 1930 (Meyer et al. 1931). The encephalitis virus Eastern (VEEV) and virus Venezuelan equine encephalitis (VEEV) were isolated respectively in 1933 and 1938 (Gibbs EP. 1976; Beck et al. 1938; Kubes et al. 1939 ). Sindbis virus isolated in Egypt in 1952 (Taylor et al. 1955), was the first Alphavirus responsible for arthritis to be isolated. The demonstration of the existence of CHIKV in Tanzania will be 1952 (Robinson 1955) (Lumsden 1955). Then follow the discoveries of all other Alphavirus. The South Elephent Seal virus (SESV), identified in 2000 on the Australian island of Macquarie is now the last Alphavirus discovered. The phylogenetic strains of Chikungunya can identify different clades for strains of East African, Western or Asian, and phylogenetic analysis is very close O'Nyong-Nyong (Powers and al. 2000), The sequencing of different isolates of the epidemic of 2005, helped to highlight some of them a mutation in the envelope glycoprotein more specifically in E1 (Schuffenecker et al. 2006). This mutation causes the substitution of an arginine at position 226 instead of valine (A226V), is a key element in determining the choice of a new vector for the transmission or Aedes albopictus (which transmits on the island of La meeting) with respect to the vector Aedes aegypti (Tsetsarkin et al. 2007). This mutation was later also found in India in 2007. (Arankalle et al. 2007; Kumar et al. 2008; Santhosh et al. 2008).The classic presentation often begins with sudden onset of high fever (40°C) for 3 / 10 days intermittent chills (Deller and al.1967). Fever is, in some cases, bi-phasic, that is to say, it decreases during a day or two before rising sharply. It is usually followed by erythema, pain or stiffness of muscle pain and muscle aches (Ozden et al. 2007) especially those involving pain in the extremities (wrists, ankles and knuckles) (Robinson 1955; Jadhav et al. 1965; Thiruvengadam et al. 1965). Also headache, rash maculopapular itchy sometimes. The rash affecting the chest and face hands and feet, children were seen eruptions like bullous skin accompanied by a detachment (Talarmin et al. 2007). The evolution of the disease regresses gradually. There is no antiviral therapy effective against CHIKV. Treatment is essentially symptomatic and consists of non-analgesic salicylates, paracetamol and anti-inflammatory drugs. This work consists of two parts: one part on the phylogenetic study of CHIKV and one part of the study of antiviral molecules. [...]

The main object of the present investigation has been to establish a titration curve for mohair keratin and to compare it with similar data for wool, to determine whether the differences in physical and chemical properties could be attributed in any way to the acidic and basic character of these fibres. As shown in subsequent discussion such measurements provide extremely useful information regarding the chemical structure of proteins in general, and in the technical fields involving processes such as wool scouring, carbonizing and dyeing. The study has been extended to include certain modified wools, i.e. photochemically damaged, and oxidized keratin. The most successful contribution to the titration data of wool keratin is the work of Steinhardt and Harris and subsequent authors have tended to adopt their procedures without modification. In the present study attempts have been made to obtain a clearer understanding of the fundamental processes. New techniques and analytical methods have been introduced to improve the accuracy of the measurements.

M.Sc. / Inorganic pollutants like heavy metals are some of the major water pollutants worldwide. They are toxic and in some cases carcinogenic even at low concentrations. Their removal from industrial aqueous solutions, wastewater and hydrometallurgical process solutions prior to their release to the environment is necessary for a healthy biosphere which includes human beings, aquatic life and plants. There are several technologies used to remove metals such as Cu, Co, Zn, Hg from water. These include among others, ion exchange, membrane filtration, activated carbon, electrochemical treatment, chemical precipitation, reverse osmosis, coagulation and flocculation. Although they have been used in the removal of metal pollutants from water, these technologies produce high quantities of sludge. They are also expensive to operate and need well trained personnel to operate large chemical plants. Since current metal removal techniques have limitations, a need exists for the development of environmentally friendly and cost effective techniques for the removal of metal ions from aqueous media. The focus of this research project is on the use of micro-organisms as biosorbents for copper and cobalt pollutants in aqueous solutions. The experimental work was carried out on a laboratory scale and a summary of our findings is presented as follows: Synthetic sulphate solutions of copper and cobalt were prepared using CuSO4. 7H2O and CoSO4. 5H2O powders. Concentrations of 0.002 M, 0.07 M and 0.2 M copper and cobalt ions in solution were used as test synthetic solutions for our experiments. Mixed strains of bioleaching bacteria were sourced from Mintek (Randburg, South Africa) to test the viability of this research project. This consortium contained Acidithiobacillus caldus, Leptospirillum spp, Ferroplasma spp and Sulphobacillus spp. These bacteria were able to remove up to 55% copper and 25% cobalt from low concentrated copper and cobalt sulphate solutions with 69% and 58% removal demonstrated in the case of mine effluents emanating from metallurgical operations. Different strains of micro-organisms (bacteria) were isolated from mine dumps and mine operation effluents and soil from the Palabora Mining Company in Limpopo, a northern province in South Africa and Nigel Town in the Gauteng Province. The isolated bacterial strains were then identified using PCR analysis and strains from the Bacillus genre were found to be predominant. Shewanella spp was also present. Pseudomonas spp was isolated using Pseudomonas agar base. These bacteria were then cultured at different species-specific culture conditions and their capabilities to remove copper and cobalt ions first from synthetic solutions and subsequently from mine effluents emanating from metallurgical operations were tested. In the first stage of biosorption experiments, factors that affect biosorption mechanisms which include, solution concentration, biomass concentration, pH, contact time and the presence of other metal co-ions were investigated. A decrease in the amount of metal sorbed as solution concentrations increased was observed with all the bacterial strains. An increase in metal sorption was also observed when biomass concentration was increased. The pH was found to be a species dependant parameter.

No description available.

No description available.